FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Zydus Pharmaceuticals Metformin Hydrochloride Tablets Recall

Metformin Hydrochloride Tablets, USP, 1000 mg, Rx only, 1000 count tablets per Bottle,…

Zydus Pharmaceuticals USA Inc · Pennington, NJ

Risk level
Class II
Reported by FDA
Aug 8, 2012
Recall ID
D-1428-2012
Check your lot numberHow we source this data

Summary

Zydus Pharmaceuticals recalled Metformin Hydrochloride Tablets starting Mar 14, 2012. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1428-2012 on Aug 8, 2012. Reason: Presence of Foreign Substance(s): A product complaint was received from a pharmacist who discovered that several tablets displayed brown specks. The same complainant also reported that metal shaving like material was observed on the surface of one tablet. Status: Terminated.

Why it was recalled

Presence of Foreign Substance(s): A product complaint was received from a pharmacist who discovered that several tablets displayed brown specks. The same complainant also reported that metal shaving like material was observed on the surface of one tablet.

Product description

Metformin Hydrochloride Tablets, USP, 1000 mg, Rx only, 1000 count tablets per Bottle, Manufactured by: Cadila Healthcare LTD. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534, NDC 68382-030-10.

Lot numbers, UPCs & expiration codes

Lot #: ML9605 Exp. 10/2013

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1428-2012
Classification
Class II
Status
Terminated
Recall initiated
Mar 14, 2012
FDA report date
Aug 8, 2012
Quantity
1176 Bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Zydus Pharmaceuticals USA Inc

Original FDA data

Every field from FDA enforcement report D-1428-2012, exactly as published.

Show all FDA fields
City
Pennington
State
NJ
Status
Terminated
Country
United States
Event ID
62605
Address
73 Route 31 N
Code information
Lot #: ML9605 Exp. 10/2013
Postal code
08534-3601
Report date
Aug 8, 2012
Product type
Drugs
Recall number
D-1428-2012
Classification
Class II
Recalling firm
Zydus Pharmaceuticals USA Inc
Product quantity
1176 Bottles
Termination date
Dec 17, 2013
Reason for recall
Presence of Foreign Substance(s): A product complaint was received from a pharmacist who discovered that several tablets displayed brown specks. The same complainant also reported that metal shaving like material was observed on the surface of one tablet.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Metformin Hydrochloride Tablets, USP, 1000 mg, Rx only, 1000 count tablets per Bottle, Manufactured by: Cadila Healthcare LTD. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534, NDC 68382-030-10.
Distribution pattern
Nationwide
Recall initiation date
Mar 14, 2012
Initial firm notification
E-Mail
Center classification date
Jul 27, 2012

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1428-2012, published Aug 8, 2012. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls